STOCK TITAN
  1. Home
  2. News
  3. WST

West Pharmaceutical Services, Inc. - WST STOCK NEWS

Welcome to our dedicated news page for West Pharmaceutical Services (Ticker: WST), a resource for investors and traders seeking the latest updates and insights on West Pharmaceutical Services.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect West Pharmaceutical Services's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of West Pharmaceutical Services's position in the market.

News
West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
Rhea-AI Summary
West Pharmaceutical Services, Inc. (WST) announced its first-quarter 2024 results, showing a decline in net sales by 3.0% and a decrease in reported-diluted EPS by 16.2%. However, adjusted-diluted EPS declined by 21.2%. The Company reaffirmed its full-year 2024 net sales guidance and raised the adjusted-diluted EPS guidance range. Additionally, a third-quarter 2024 dividend of $0.20 per share was declared. The Company is actively managing costs and making strategic investments for future growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.55%
Tags
dividends earnings
-
News
West to Host First-Quarter 2024 Conference Call
Rhea-AI Summary
West Pharmaceutical Services, Inc. (WST) will release its first-quarter financial results on April 25, 2024, followed by a conference call to discuss business expectations. Participants can register in advance to ask questions to Management.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.56%
Tags
conferences
-
News
West to Participate in Upcoming Investor Conferences
Rhea-AI Summary
West Pharmaceutical Services, Inc. (WST) will present at two upcoming healthcare conferences in March 2024, providing opportunities for investors to learn about the company's latest developments.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.29%
Tags
conferences
News
West Announces Second-Quarter 2024 Dividend
Rhea-AI Summary
West Pharmaceutical Services, Inc. declares a dividend of $0.20 per share for the second quarter of 2024, payable on May 1, 2024, to shareholders of record as of April 24, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.28%
Tags
dividends
-
News
West Announces Fourth-Quarter and Full-Year 2023 Results
Rhea-AI Summary
West Pharmaceutical Services, Inc. (WST) reported strong financial results for Q4 and full-year 2023, with net sales growth and EPS increases. The company introduced 2024 financial guidance with expected organic sales growth and adjusted EPS range. The Proprietary Products segment saw growth in HVP components and devices, while the Contract-Manufactured Products segment showed growth in medical device and diagnostic products.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.08%
Tags
earnings
-
News
West Named to Newsweek's America's Greatest Workplaces 2024 for Diversity
Rhea-AI Summary
West Pharmaceutical Services, Inc. (WST) has been recognized as one of America's Greatest Workplaces for Diversity 2024 by Newsweek and Plant-A Insights Group. The company's commitment to diversity, equity, and inclusion is evident through its global impact and long-standing dedication. West's emphasis on diversity is reflected in its recruitment strategy, with 44% of senior leaders being women and/or people of color, and 53% of them being promoted to senior leadership in 2023. Additionally, West supports underserved communities through donations of over $1 million annually to over 40 charities. This recognition highlights West's efforts in fostering a diverse and inclusive work environment, which is crucial for attracting top talent and business partnerships.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.7%
Tags
none
News
West to Host Fourth-Quarter and Full-Year 2023 Conference Call
Rhea-AI Summary
West Pharmaceutical Services, Inc. (WST) will release its fourth-quarter and full-year 2023 financial results on February 15, 2024. The company will host a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. Participants can register in advance to ask questions to Management during the call. The live audio webcast and slide presentation will be available on the Company's website, with replays accessible for 30 to 90 days.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.27%
Tags
conferences
-
News
West Announces First-Quarter 2024 Dividend
Rhea-AI Summary
West Pharmaceutical Services, Inc. (NYSE: WST) declares a first-quarter 2024 dividend of $0.20 per share, to be paid on February 7, 2024, to shareholders of record as of January 31, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.16%
Tags
dividends
-
News
West Receives FDA 510(k) Clearance for Vial2Bag Advanced® 13mm Admixture Device
Rhea-AI Summary
West Pharmaceutical Services, Inc. (NYSE: WST) has announced the FDA 510(k) clearance and launch of its Vial2Bag Advanced® 13mm admixture device, complementing its existing 20mm admixture device. The new device offers needle-free reconstitution and transfer of drugs using either a 13mm or 20mm vial and an IV bag, addressing the need for more drug preparation and delivery options at the point-of-care.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.26%
Tags
clinical trial
News
West to Participate in Upcoming Investor Conferences
Rhea-AI Summary
West Pharmaceutical Services, Inc. will be presenting at the Jefferies Healthcare Conference in London on November 14, 2023, and at the Stephens Annual Investment Conference in Nashville on November 16, 2023. A live audio webcast will be available on the company's website, and replays will be accessible for 90 days after the events.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.07%
Tags
conferences
Stock WST logo
West Pharmaceutical Services, Inc.

NYSE:WST

WST Rankings

#416 Ranked by Market Cap
#521 Ranked by Stock Gains
#2078 Ranked by Dividends

WST Stock Data

27.82B
72.82M
0.56%
95.9%
1.55%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
US
Exton

About WST

west works side-by-side with healthcare partners from concept to the patient, designing and manufacturing packaging and delivery systems that promote efficiency, reliability and safety. west leads the way with cutting-edge technologies and quality systems, a thorough understanding of global regulatory compliance, and an unmatched knowledge of relevant pharmaceutical product testing, development and packaging. west supports customers from sales, manufacturing, and research and development locations in north and south america, europe, asia and australia.